NLRP3 and familial dilated cardiomyopathy: The next research will focus on in vitro cellular mechanisms, such as adding a specific inhibitor of NLRP3 or using NLRP3 gene silencing in the experiment, in an attempt to better clarify the mechanism of SMY in the prevention and treatment of DCM and provide a new research direction for the treatment of DCM.